Polar Asset Management Partners’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Polar Asset Management Partners’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-181,200	Closed	-$3.26M	–	808
2020 Q2	$3.26M	Buy	+181,200	New	+$2.52M	0.05%	260

Polar Asset Management Partners's PTLA Position: Q3 2020 in Review

Polar Asset Management Partners sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 181,200 shares — an estimated $3.26M sold.

Polar Asset Management Partners first reported a position in PTLA in Q2 2020 and held it in 1 quarter. The position peaked at $3.26M in Q2 2020. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Polar Asset Management Partners reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Polar Asset Management Partners sold 181,200 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $3.26M.
Polar Asset Management Partners first reported a position in Portola Pharmaceuticals, Inc. in Q2 2020 and held it in 1 quarter.
Polar Asset Management Partners's Portola Pharmaceuticals, Inc. position peaked at $3.26M in Q2 2020.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Polar Asset Management Partners's 13F filing for Q3 2020, filed 16 Nov 2020.